Implications of apathy for everyday functioning outcomes in persons living with HIV infection
- PMID: 22705481
- PMCID: PMC3399510
- DOI: 10.1093/arclin/acs055
Implications of apathy for everyday functioning outcomes in persons living with HIV infection
Abstract
Apathy is a relatively common clinical feature of HIV-Associated Neurocognitive Disorders, but little is known about its implications for everyday functioning outcomes. In the present study, we examined the associations between apathy and self-reported instrumental activities of daily living (IADL) and neurocognitive complaints in 75 participants with HIV infection and 52 demographically comparable seronegative comparison subjects. All volunteers completed the apathy subscale of the Frontal Systems Behavioral Scale as part of a comprehensive neuromedical, psychiatric, and neurocognitive research evaluation. When compared with the seronegative comparison participants, the HIV+ group reported significantly higher current levels of apathy, but did not differ in self-report of prior (i.e., pre-seroconversion) apathy. Higher current apathy self-ratings were associated with greater severity of IADL declines and more numerous cognitive complaints in the HIV+ sample, even after adjusting for potential psychiatric (e.g., depression), medical (e.g., hepatitis C co-infection), and neurocognitive predictors. Cognitive complaints, but not IADLs, were also uniquely associated with ratings of executive dysfunction and disinhibition. All told, these findings suggest that apathy may make a unique contribution to important everyday functioning outcomes among persons living with HIV infection. The clinical detection of apathy may help identify HIV-infected individuals at particular risk for functional impairments who may require additional support to maintain independence.
References
-
- Atkinson J. H., Grant I., Kennedy C. J., Richman D. D., Spector S. A., McCutchan J. A. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: A controlled study. Archives of General Psychiatry. 1988;45(9):859. doi:10.1001/archpsyc.1988.01800330091011. - DOI - PubMed
-
- Atkinson J. H., Heaton R. K., Patterson T. L., Wolfson T., Deutsch R., Brown S. J., et al. Two-year prospective study of major depressive disorder in HIV-infected men. Journal of Affective Disorders. 2008;108(3):225–234. doi:10.1016/j.jad.2007.10.017. - DOI - PMC - PubMed
-
- Barclay T. R., Hinkin C. H., Castellon S. A. Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychology. 2007;26(1):40–49. doi:10.1037/0278-6133.26.1.40. - DOI - PMC - PubMed
-
- Basso M. R., Bornstein R. A. Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection. Journal of Clinical and Experimental Neuropsychology. 2000;22(1):104–114. doi:10.1076/1380-3395(200002)22:1;1-8;FT104. - DOI - PubMed
-
- Bing E. G., Burnam M. A., Longshore D., Fleishman J. A., Sherbourne C. D., London A. S., et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry. 2001;58(8):721. doi:10.1001/archpsyc.58.8.721. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
